Similar articles

• [Atherogenic dyslipidaemia in type 2 diabetes].

  Zozulińska D. Zozulińska D. Kardiol Pol. 2006 Oct;64(10 Suppl 6):S567-71. Kardiol Pol. 2006. PMID: 20527378 Review. Polish.
• Dyslipidemia, but not hyperglycemia and insulin resistance, is associated with marked alterations in the HDL lipidome in type 2 diabetic subjects in the DIWA cohort: impact on small HDL particles.

  Ståhlman M, Fagerberg B, Adiels M, Ekroos K, Chapman JM, Kontush A, Borén J. Ståhlman M, et al. Biochim Biophys Acta. 2013 Nov;1831(11):1609-17. doi: 10.1016/j.bbalip.2013.07.009. Epub 2013 Jul 27. Biochim Biophys Acta. 2013. PMID: 23896361
• [The possible role of adipose tissue in insulin resistance and in the physiopathology of obese diabetics].

  Guy-Grand B, Bour H. Guy-Grand B, et al. Journ Annu Diabetol Hotel Dieu. 1972;13(0):81-92. Journ Annu Diabetol Hotel Dieu. 1972. PMID: 4606004 Review. French. No abstract available.
• Lipid and glucose alterations in perinatally-acquired HIV-infected adolescents and young adults.

  Blázquez D, Ramos-Amador JT, Saínz T, Mellado MJ, García-Ascaso M, De José MI, Rojo P, Navarro ML, Muñoz-Fernández MÁ, Saavedra J, Roa MA, Jiménez S, Beceiro J, Prieto L, Hortelano MG, González-Tomé MI. Blázquez D, et al. BMC Infect Dis. 2015 Mar 8;15:119. doi: 10.1186/s12879-015-0853-8. BMC Infect Dis. 2015. PMID: 25880777 Free PMC article.
• Dyslipidemia and diabetes: reciprocal impact of impaired lipid metabolism and Beta-cell dysfunction on micro- and macrovascular complications.

  Bardini G, Rotella CM, Giannini S. Bardini G, et al. Rev Diabet Stud. 2012 Summer-Fall;9(2-3):82-93. doi: 10.1900/RDS.2012.9.82. Epub 2012 Nov 15. Rev Diabet Stud. 2012. PMID: 23403704 Free PMC article. Review.